Trial · NCT06609343
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
NCT06609343, Phase 1, Phase 2, Not yet recruiting, The University of Texas Health Science Center at San Antonio
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis. Trials, record NCT06609343. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06609343
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
- NCT number
- NCT06609343
- Status
- Not yet recruiting
- Phases
- Phase 1, Phase 2
- Enrollment
- 16 participants, estimated
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Conditions
- End Stage Renal Disease, Fatigue
- Interventions
- Bupropion Hydrochloride 150 MG
- First posted
- 2024-09-24
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Brief Fatigue Inventory (BFI) Global Score | Baseline to 8 weeks | This inventory contains 9 items scored from 0-10 with a total possible raw score of 0-90. A lower score indicates that there is less fatigue |
| Secondary | Change in plasma concentration of inflammatory marker IL-6 | Baseline to 8 weeks | Plasma level of inflammatory marker of interleukin-6 (IL-6) |
| Secondary | Change in plasma concentration of inflammatory marker TNF-α | Baseline to 8 weeks | Plasma level of tumor necrosis factor-alpha (TNF-α) |
| Other | Change in Cognitive function using Trail Making Test B | Baseline to 8 weeks | The participant will need a pencil to perform each part. The examiner starts timing as soon as the instructions are completed and the participant is signaled to begin. Timing is continued until the participant completes or discontinues the test. The time to completion in seconds is recorded. The maximum score for Part B is 300 seconds with 301" indicating the test was discontinued. A lower score indicates that the participant has better cognitive function and completed the task faster. |
| Other | Change in Mini-COG score | Baseline to 8 weeks | The score is made up of 2 parts: recall score is 0-3 points, 1 point is assigned for each word correctly recalled without prompt, so the score is higher if more words are recalled. For the clock drawing score, the possible score is 0-2 points, a higher score indicates more accuracy. The total score is between 0-5 with a higher score indicating better cognitive function. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Clock Drawing Task | Other outcome | ConductCognition |
| Trail Making Test A | Other outcome | ConductCognition |
| Trail Making Test B | Other outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06609343
GET https://conductscience.org/api/trials/v1/NCT06609343/registered